Over 200,000 people have undergone transcatheter aortic valve replacement (TAVR), and every year approximately 140,000 patients receive a surgical bioprosthetic valve. 1,2 Despite this increasing volume, the optimal postoperative anticoagulation strategy is often unclear. Anticoagulation in patients with heart valve replacements - Guideline for primary and secondary care. Dr. Christoph Mädler, Consultant Cardiologist, ABUHB Dr. Sarah Lewis, Consultant Haematologist, ABUHB Dr. Alun Edwards, General Practitioner, ABUHB Prof. Ulrich von Oppell, Consultant Cardiac Surgeon, C&VUHB N.B. Staff should be discouraged from printing this document. This is to avoid the. All patients with a mechanical valve prosthesis require anticoagulant treatment using warfarin or coumadin. Current guidelines recommend a treatment intensity at an international normalised ratio (INR) of 2.0–3.0 for bileaflet or Medtronic Hall valves in the aortic position (after the first three The long-term risk of thromboembolism is generally lower with bioprosthetic valves, though there is a risk of thromboembolism for bioprosthetic as well as mechanical valves early after valve implantation. The only reason a tissue valve recipient would need coumadin is for a heart beat problem unrelated to the valve. The only other reason would be if the tissue valve wore out and the individual had a mechanical valve implanted. Summary. A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was whether warfarin should be routinely prescribed for the first three months after a bioprosthetic valve replacement either for the aortic or mitral position. Coumadin ® is indicated for: • Prophylaxis and treatment of venous thrombosis and its extension, pulmonary embolism (PE). • Prophylaxis and treatment of thromboembolic complications associated with atrial fibrillation (AF) and/or cardiac valve replacement. User Reviews for Coumadin to treat Prosthetic Heart Valves, Tissue Valves - Thrombosis Prophylaxis The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care. After valve repair with a mechanical device. (ACCP) and the American College of Cardiology (ACC)/American Heart Association (AHA) 12,13 provide fairly similar recommendations regarding the use of anticoagulation (Tables 1 and 2). The mainstay of treatment in both guidelines remains indefinite anticoagulation with a vitamin K antagonist (VKA). The benefits of VKA therapy after mechanical. Coumadin Therapy After Mechanical Valve Replacement Surgery By Adam Pick - Patient, Author & HeartValveSurgery.com Founder If you suffer from severe valve disease, including aortic stenosis or mitral regurgitation, you may be required to select a heart valve replacement if your valve can not be repaired.